Masucci, Luca
 Distribuzione geografica
Continente #
EU - Europa 2.258
NA - Nord America 2.255
AS - Asia 668
AF - Africa 13
OC - Oceania 13
SA - Sud America 11
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.219
Nazione #
US - Stati Uniti d'America 2.236
IT - Italia 494
SE - Svezia 475
DE - Germania 408
CN - Cina 266
PL - Polonia 224
FR - Francia 173
SG - Singapore 166
IE - Irlanda 144
UA - Ucraina 100
ID - Indonesia 80
GB - Regno Unito 63
IN - India 57
RU - Federazione Russa 48
FI - Finlandia 39
TR - Turchia 28
CA - Canada 17
BE - Belgio 16
NL - Olanda 16
CZ - Repubblica Ceca 15
KR - Corea 14
AU - Australia 13
CH - Svizzera 11
IR - Iran 10
JP - Giappone 9
PH - Filippine 8
AT - Austria 7
ES - Italia 7
HK - Hong Kong 6
BR - Brasile 5
VN - Vietnam 5
CI - Costa d'Avorio 4
GR - Grecia 4
CY - Cipro 3
NG - Nigeria 3
NO - Norvegia 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
CL - Cile 2
GE - Georgia 2
HR - Croazia 2
LT - Lituania 2
NP - Nepal 2
RO - Romania 2
TH - Thailandia 2
ZA - Sudafrica 2
AL - Albania 1
AR - Argentina 1
BD - Bangladesh 1
CO - Colombia 1
EC - Ecuador 1
EG - Egitto 1
EU - Europa 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
LV - Lettonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
PE - Perù 1
PK - Pakistan 1
SN - Senegal 1
TN - Tunisia 1
TZ - Tanzania 1
Totale 5.219
Città #
Chandler 441
Warsaw 218
Ashburn 184
Dublin 143
Ann Arbor 116
Singapore 113
Fairfield 83
Jacksonville 81
Rome 81
Jakarta 80
New York 69
Woodbridge 69
Wilmington 67
Milan 62
San Mateo 61
Dearborn 54
Marseille 54
Boston 52
Nanjing 46
Beijing 43
Princeton 43
Cattolica 41
Moscow 38
Houston 37
Chicago 36
Seattle 33
Redwood City 30
Izmir 25
Pune 25
Boardman 23
Nürnberg 22
Lawrence 21
Cambridge 19
Los Angeles 18
Redmond 18
Hangzhou 16
Munich 16
Nanchang 15
Seoul 14
Augusta 13
Falls Church 13
Kunming 13
London 13
Zhengzhou 13
Hebei 11
Melbourne 11
Mountain View 11
Norwalk 11
Shanghai 11
Shenyang 11
Tianjin 11
Brussels 10
Helsinki 10
Washington 10
Paris 9
Zurich 8
Florence 7
Ceska 6
Fremont 6
Hong Kong 6
Lancaster 6
Toronto 6
Brno 5
Busto Arsizio 5
Dong Ket 5
Edinburgh 5
Genoa 5
Stockholm 5
University Park 5
Vienna 5
Abidjan 4
Bolzano 4
Bremen 4
Changsha 4
Greencastle 4
Guangzhou 4
Inverness 4
Jiaxing 4
Jinan 4
Lanzhou 4
Lappeenranta 4
Leawood 4
Manfredonia 4
Ottawa 4
Parma 4
San Diego 4
Settimo Torinese 4
Spring Hill 4
Trieste 4
Venice 4
Verona 4
Acireale 3
Agrate Conturbia 3
Aubel 3
Bitonto 3
Bologna 3
Detroit 3
Falkenstein 3
Famagusta 3
Fiano Romano 3
Totale 2.984
Nome #
Intestinal parasites isolated in a large teaching hospital, Italy, 1 May 2006 to 31 December 2008 381
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice 190
Donor program for fecal microbiota transplantation: A 3-year experience of a large-volume Italian stool bank 154
The role of diet on gut microbiota composition 148
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis 132
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. 131
Fecal Microbiota Transplantation: A Potential Tool for Treatment of Human Female Reproductive Tract Diseases 131
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders? 129
The effect of different antibiotic regimens on bacterial resistance: a systematic review 120
Faecal transplantation for Clostridium difficile infection. Three cases treated in Italy 113
Monoclonal antibody fragment from combinatorial phage display library neutralizes alpha-latrotoxin activity and abolishes black widow spider venom lethality, in mice 112
Polymerase chain reaction-reverse cross-blot hybridization assay in the diagnosis of sporotrichoid Mycobacterium marinum infection 105
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin 102
Molecular and epidemiological characterization of vaginal Saccharomyces cerevisiae isolates 101
Entamoeba dispar: A Rare Case of Enteritis in a Patient Living in a Nonendemic Area 97
A patient with acute myeloid leukemia and a solid mass in the colon. 96
In vitro effect of clarithromycin and alginate lyase against helicobacter pylori biofilm 94
Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a three-year, single-centre cohort study 92
Risk factors and clinical outcomes of candidaemia in patients treated for Clostridium difficile infection 91
Effective use of nitrocellulose-blotted antigens for phage display monoclonal antibody selection. 89
European consensus conference on faecal microbiota transplantation in clinical practice 86
In vitro activity of bergamot natural essence and furocoumarin-free and distilled extracts, and their associations with boric acid, against clinical yeast isolates. 84
Principles of DNA-Based Gut Microbiota Assessment and Therapeutic Efficacy of Fecal Microbiota Transplantation in Gastrointestinal Diseases 84
Multiple malaria infection in a pregnant woman from Nigeria: detection by multiplex PCR 83
Impact evaluation of a Critical Pathway for patients with Clostridium difficile infection: A pre-post analysis in a Third Level Referral Center 79
Impact evaluation of a Critical Pathway for patients with Clostridium difficile infection: a pre-post analysis in a Third Level Referral Center 78
Intestinal Parasitic Infections in Internationally Adopted Children: A 10-Year Retrospective Study 76
FETR-ALS Study Protocol: A Randomized Clinical Trial of Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis 72
Effects of proton pump inhibitors on the gastric mucosa-associated microbiota in dyspeptic patients 71
Reply to Seligman 69
Culture-guided treatment approach for Helicobacter pylori infection: review of the literature 67
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. 67
Clostridium difficile: trend in an Italian Tertiary Care Hospital during fifteen years, 2002-2016 67
Whole-genome sequencing reveals host factors underlying critical COVID-19 65
Liver Injury, Endotoxemia, and Their Relationship to Intestinal Microbiota Composition in Alcohol-Preferring Rats 60
Conjonctival papilloma and human papillomavirus: identification of HPV types by PCR. 57
Characterizing peri-implant and sub-gingival microbiota through culturomics. First isolation of some species in the oral cavity. A pilot study 57
Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection—single versus multiple infusions 55
Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic 54
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma 53
Esophageal microbiome signature in patients with Barrett’s esophagus and esophageal adenocarcinoma 49
Actoxumab + bezlotoxumab combination: what promise for Clostridium difficile treatment? 48
Nonlinear machine learning pattern recognition and bacteria-metabolite multilayer network analysis of perturbed gastric microbiome 48
An explainable model of host genetic interactions linked to COVID-19 severity 47
Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With Recurrent Clostridioides difficile Infection Treated With Fecal Microbiota Transplantation or Antibiotics: A Prospective Cohort Study 47
Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center 46
Laboratory handling practice for faecal microbiota transplantation 46
Use of Faecal Transplantation with a Novel Diet for Mild to Moderate Active Ulcerative Colitis: The CRAFT UC Randomised Controlled Trial 45
Clostridioides difficile Infection in Children: A 5-Year Multicenter Retrospective Study 44
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. 41
PCR-reverse cross blot hybridization assay as an useful diagnostic tool in a case of Mycobacterium marinum sporotrichoid infection 41
Laboratory handling practice for faecal microbiota transplantation 41
Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center 41
SARS-CoV-2 vaccines and donor recruitment for FMT 40
Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection-single versus multiple infusions 39
Increased Faecalibacterium abundance is associated with clinical improvement in patients receiving rifaximin treatment 39
Celiac Disease Predisposition and Genital Tract Microbiota in Women Affected by Recurrent Pregnancy Loss 38
Validation of Two Commercial Multiplex Real-Time PCR Assays for Detection of SARS-CoV-2 in Stool Donors for Fecal Microbiota Transplantation 38
A literature review of metagenomics and culturomics of the peri-implant microbiome: Current evidence and future perspectives 36
The Italian national faecal microbiota transplantation program: A coordinated effort against Clostridioides difficile infection 35
Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study 34
Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis 33
Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases 32
Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic 30
Fecal microbiota transplantation: What’s new? 29
Minimising the risk of monkeypox virus transmission during faecal microbiota transplantation: recommendations from a European expert panel 29
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 27
Culturomic and quantitative real-time-polymerase chain reaction analyses for early contamination of abutments with different surfaces: A randomized clinical trial 27
Fecal Microbiota Transplantation and Other Gut Microbiota Manipulation Strategies 26
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease 26
Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases 25
Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes 25
Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel 24
How the gut parasitome affects human health 21
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 21
comparison of the mycobacteria growth indicator tube with radiometric and solid culture for isolation of mycobacteria from clinical specimens and susceptibility testing of Mycobacterium tuberculosis 18
Fecal microbiota transplantation for the treatment of steroid-refractory, intestinal, graft-versus-host disease in a pediatric patient 16
Fecal microbiota transplantation for recurrent Clostridioides difficile infection in patients with concurrent ulcerative colitis 15
Donor screening for fecal microbiota transplantation with a direct stool testing-based strategy: a prospective cohort study 13
Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study 12
Totale 5.324
Categoria #
all - tutte 25.236
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.236


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020523 0 0 56 38 49 71 83 34 55 23 63 51
2020/2021491 43 62 15 42 67 43 62 8 54 21 63 11
2021/2022611 69 27 18 29 35 27 10 68 34 34 155 105
2022/20231.475 195 176 90 155 104 165 89 127 194 95 53 32
2023/2024943 59 225 39 66 44 146 77 25 19 50 93 100
2024/2025241 39 70 132 0 0 0 0 0 0 0 0 0
Totale 5.324